An article from yesterday's New York Times details the coming challenges in deriving food from genetically modified organisms, particularly here in the US, where so far there aren't a lot of guidelines on the subject. Getting FDA to "spell out the rules of the game," the article says, could be the encouragement investors need to get active in this area -- while others contend that such guidelines would scare the public by having the GMO term associated with this food.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.